Financhill
Sell
36

ADXN Quote, Financials, Valuation and Earnings

Last price:
$7.32
Seasonality move :
-25.63%
Day range:
$6.94 - $7.55
52-week range:
$6.67 - $27.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.12x
P/B ratio:
0.58x
Volume:
5.4K
Avg. volume:
9.8K
1-year change:
-35.75%
Market cap:
$7.6M
Revenue:
$1.8M
EPS (TTM):
-$0.34

Earnings Data

Next earnings date for ADXN
--
Most recent earnings per share
-$2.78
Missed by $2.78
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADXN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $236.3K -- -- -- --
12/31/2024 Q4 $177.2K -- -- -- --
09/30/2024 Q3 $130K $62.3K -$2.78 -- --
06/30/2024 Q2 $262.6K $127.5K $10.62 -- --
03/31/2024 Q1 $266.4K $267.2K -$4.12 -- --
12/31/2023 Q4 $717.5K $173.2K -$4.06 -- --
09/30/2023 Q3 $706.5K $371.1K -$4.08 -- --
08/18/2023 Q2 -- $701.9K -$5.34 -- --
03/31/2023 Q1 -- $540.9K -$5.18 -- --
12/31/2022 Q4 -- $615.7K -$4.99 -- --
09/30/2022 Q3 $232.6K $423.9K -$11.18 -- --
08/18/2022 Q2 -- $190K -$23.63 -- --
05/05/2022 Q1 -- $256.8K -$19.49 -- --
03/10/2022 Q4 -- $431.2K -$16.92 -- --
11/01/2021 Q3 -- $742.9K -$14.38 -- --
08/05/2021 Q2 -- $1.1M -$18.45 -- --
05/03/2021 Q1 -- $933.4K -$10.61 -- --
03/08/2021 Q4 -- $2M -$10.62 -- --
11/02/2020 Q3 -- $29.7K -$15.66 -- --
08/12/2020 Q2 -- $893.2K -$14.94 -- --
03/31/2020 Q1 -- $934.3K -$19.84 -- --
12/31/2019 Q4 -- $1.1M -$16.97 -- --
09/30/2019 Q3 -- $509.9K -$17.05 -- --
06/30/2019 Q2 -- $518K -$20.34 -- --
03/31/2019 Q1 -- $703.4K -$14.45 -- --

Addex Therapeutics Earnings Questions

  • How Much did Addex Therapeutics Generate in Revenue Last Quarter?

    Addex Therapeutics reported $62.3K worth of top line sales in its most recent quarter.

  • Did Addex Therapeutics Beat Earnings Last Quarter?

    Addex Therapeutics announced earnings per share of -$2.78 which represents a miss of analyst forecast a -- per share.

  • Is Addex Therapeutics Profitable?

    Addex Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Addex Therapeutics EPS Next Year?

    Addex Therapeutics's earnings are forecast to grow from -$18.71 per share to -- per share next year representing an increase of --.

  • When is Addex Therapeutics's Earnings Date?

    Currently, Addex Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Alerts

Sell
5
CABO alert for Mar 14

Cable One [CABO] is down 3.74% over the past day.

Sell
38
ADBE alert for Mar 14

Adobe [ADBE] is up 4.33% over the past day.

Sell
29
CAR alert for Mar 14

Avis Budget Group [CAR] is up 7.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock